Abstract:The current crises in opioid abuse and chronic pain call for the development of nonopioid and nonpharmacological therapeutics for pain relief. Neuromodulation-based approaches, such as spinal cord stimulation, dorsal root ganglion simulation, and nerve stimulation including vagus nerve stimulation, have shown efficacy in achieving pain control in preclinical and clinical studies. However, the mechanisms by which neuromodulation alleviates pain are not fully understood. Accumulating evidence suggests that neuromodulation regulates inflammation and neuroinflammation—a localized inflammation in peripheral nerves, dorsal root ganglia/trigeminal ganglia, and spinal cord/brain—through neuro-immune interactions. Specialized proresolving mediators (SPMs) such as resolvins, protectins, maresins, and lipoxins are lipid molecules produced during the resolution phase of inflammation and exhibit multiple beneficial effects in resolving inflammation in various animal models. Recent studies suggest that SPMs inhibit inflammatory pain, postoperative pain, neuropathic pain, and cancer pain in rodent models via immune, glial, and neuronal modulations. It is noteworthy that sham surgery is sufficient to elevate resolvin levels and may serve as a model of resolution. Interestingly, it has been shown that the vagus nerve produces SPMs and vagus nerve stimulation (VNS) induces SPM production <i>in vitro</i>. In this review, we discuss how neuromodulation such as VNS controls pain via immunomodulation and neuro-immune interactions and highlight possible involvement of SPMs. In particular, we demonstrate that VNS via auricular electroacupuncture effectively attenuates chemotherapy-induced neuropathic pain. Furthermore, auricular stimulation is able to increase resolvin levels in mice. Thus, we propose that neuromodulation may control pain and inflammation/neuroinflammatioin via SPMs. Finally, we discuss key questions that remain unanswered in our understanding of how neuromodulation-based therapies provide short-term and long-term pain relief.

Interventional Therapy for Neuropathic Pain

Interventional Treatment of Neuropathic Pain

Non-invasive Brain Stimulation Interventions for Management of Chronic Central Neuropathic Pain: a Scoping Review Protocol

Experts consensus on minimally invasive therapy techniques for the treatment of pain related to posterior ramus of spinal nerve in China (2021)

Advances in the interventional management of neuropathic pain

Minimally Invasive Interventional Therapy for Pain

Progress in Treatment of Pathological Neuropathic Pain after Spinal Cord Injury

Neuromodulation for Neuropathic Pain Syndromes

Potential Novel Therapeutic Strategies for Neuropathic Pain

Pain Management in Neurosurgery: Back and Lower Extremity Pain, Trigeminal Neuralgia

Pharmacotherapy and noninvasive neurostimulation for neuropathic pain

Non-invasive Brain Stimulation for Central Neuropathic Pain

Novel Therapies for the Treatment of Neuropathic Pain: Potential and Pitfalls

Overcoming clinical challenges of refractory neuropathic pain

Stem Cells in the Treatment of Neuropathic Pain: Research Progress of Mechanism

Future Treatment of Neuropathic Pain in Spinal Cord Injury: The Challenges of Nanomedicine, Supplements or Opportunities?

Cell therapy for neuropathic pain

An overview of the non‐procedural treatment options for peripheral neuropathic pain

Recent advances in nanoplatforms for the treatment of neuropathic pain

Neuromodulation, Specialized Proresolving Mediators, and Resolution of Pain

Neuropathic Pain: From Mechanisms to Treatment